# Elekta
---
Who / What
Elekta is a global Swedish company specializing in the development and production of advanced radiation therapy and radiosurgery equipment. Their technology is pivotal in treating cancer and brain disorders, offering cutting-edge solutions for clinical oncology.
---
Background & History
Founded in 1984 in Uppsala, Sweden, Elekta emerged from the need to innovate in medical imaging and radiotherapy. The company initially focused on developing linear accelerators, later expanding into radiosurgery systems like the **Synergy** platform. Over decades, Elekta has grown into a leader in precision oncology, driven by mergers (e.g., acquisition of **Accuray Inc.** in 2018) and partnerships with academic institutions.
---
Why Notable
Elekta’s technology is critical to modern cancer treatment, enabling highly targeted radiation therapy that minimizes damage to healthy tissues. Their innovations, such as **Image-Guided Radiation Therapy (IGRT)** and **Intensity-Modulated Radiation Therapy (IMRT)**, have improved survival rates for patients with brain tumors and other cancers. The company’s global footprint ensures accessibility in over 120 countries, making it a cornerstone of medical advancements in oncology.
---
In the News
Elekta remains at the forefront of precision medicine, with recent focus on AI-driven diagnostics (e.g., **AI-powered treatment planning**) and collaborations to expand its reach in emerging markets. The company’s post-acquisition growth under Accuray has solidified its role as a key player in the $100+ billion radiation therapy market, driving innovation amid rising demand for advanced cancer treatments.
---
Key Facts
---
